|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225.00 SEK | +1.08% |
|
-3.35% | -10.36% |
| 21/01 | Sectra Secures Expanded Deal for Enterprise Imaging System in Germany | MT |
| 21/01 | Tum Klinikum expands enterprise imaging solution from Sectra | RE |
| Capitalization | 4.29TCr 470.84Cr 402.57Cr 373.7Cr 350.48Cr 650.21Cr 43TCr 696.24Cr 1.7TCr 20TCr 1.77TCr 1.73TCr 74TCr | P/E ratio 2026 * |
78.8x | P/E ratio 2027 * | 63.9x |
|---|---|---|---|---|---|
| Enterprise value | 4.19TCr 459.93Cr 393.24Cr 365.04Cr 342.36Cr 635.14Cr 42TCr 680.1Cr 1.66TCr 20TCr 1.72TCr 1.69TCr 73TCr | EV / Sales 2026 * |
11.9x | EV / Sales 2027 * | 10.2x |
| Free-Float |
66.06% | Yield 2026 * |
0.94% | Yield 2027 * | 0.85% |
Last Transcript: Sectra AB
| 1 day | +1.08% | ||
| 1 week | -3.35% | ||
| Current month | -10.36% | ||
| 1 month | -11.07% | ||
| 3 months | -25.79% | ||
| 6 months | -37.40% | ||
| Current year | -10.36% |
| 1 week | 219.4 | 237.4 | |
| 1 month | 219.4 | 255.2 | |
| Current year | 219.4 | 250.8 | |
| 1 year | 219.4 | 377.4 | |
| 3 years | 117.1 | 377.4 | |
| 5 years | 107.2 | 377.4 | |
| 10 years | 19.3 | 377.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 01/11/2012 | |
| Director of Finance/CFO | 50 | 20/03/2022 | |
Per Andersnäs
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/1997 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 06/09/2018 | |
| Director/Board Member | 69 | 01/01/1985 | |
Tomas Puusepp
BRD | Director/Board Member | 71 | 01/01/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.08% | -3.35% | -10.22% | +37.41% | 470.84Cr | ||
| +1.60% | +0.40% | -1.48% | +35.27% | 3.61TCr | ||
| -0.52% | -14.02% | -33.82% | +180.64% | 1.26TCr | ||
| +3.33% | +1.64% | - | - | 416.66Cr | ||
| -1.87% | -4.09% | - | - | 285.71Cr | ||
| +0.47% | +8.22% | - | - | 281.08Cr | ||
| +2.89% | -0.47% | +17.64% | -9.86% | 226.54Cr | ||
| -1.71% | -13.86% | +9.59% | - | 145.1Cr | ||
| -0.88% | -9.18% | +30.56% | -40.32% | 125.09Cr | ||
| Average | +0.49% | -4.45% | +2.04% | +40.63% | 758.13Cr | |
| Weighted average by Cap. | +1.01% | -3.45% | -7.46% | +64.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 350.96Cr 39Cr 33Cr 31Cr 29Cr 53Cr 3.53TCr 57Cr 138.88Cr 1.67TCr 144.49Cr 141.54Cr 6.09TCr | 411.26Cr 45Cr 39Cr 36Cr 34Cr 62Cr 4.14TCr 67Cr 162.74Cr 1.95TCr 169.31Cr 165.85Cr 7.14TCr |
| Net income | 54Cr 5.97Cr 5.1Cr 4.74Cr 4.44Cr 8.24Cr 546.85Cr 8.83Cr 22Cr 258.45Cr 22Cr 22Cr 944.07Cr | 67Cr 7.38Cr 6.31Cr 5.86Cr 5.49Cr 10Cr 675.77Cr 11Cr 27Cr 319.38Cr 28Cr 27Cr 1.17TCr |
| Net Debt | -99Cr -11Cr -9.33Cr -8.66Cr -8.12Cr -15Cr -999.58Cr -16Cr -39Cr -472.42Cr -41Cr -40Cr -1.73TCr | -108.2Cr -12Cr -10Cr -9.43Cr -8.84Cr -16Cr -1.09TCr -18Cr -43Cr -514.24Cr -45Cr -44Cr -1.88TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | 225.00 kr | +1.08% | 33,654 |
| 21/26/21 | 222.60 kr | -2.28% | 2,05,741 |
| 20/26/20 | 227.80 kr | +1.42% | 4,10,974 |
| 19/26/19 | 224.60 kr | -2.43% | 85,298 |
| 16/26/16 | 230.20 kr | -2.95% | 1,29,123 |
Delayed Quote Nasdaq Stockholm, January 22, 2026 at 04:28 pm IST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SECT B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















